These can vary in severity and may include: Common Side Effects: Gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, stomach pain, excessive burping, and indigestion are frequently reported, especially when starting the medication or increasing dosage
Coverage of the drugs will expand starting next year, according to a senior Trump administration official, for people who have severe obesity and others who are overweight or obese and have serious health problems
Pancreatic inflammation and cancer Although definitive evidence is lacking, GLP-1-RAs have been linked with pancreatitis as well as pancreatic cancer
Multi-Pathway Weight Management Research Retatrutides triple-agonist mechanism allows researchers to study weight regulation through multiple complementary pathways at onceappetite suppression, glucose control, and energy expendituresupporting more comprehensive models of sustained weight-loss biology
Pang LH, Li MJ, Li MQ, Yang DM, Shi L